Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis

Jerzy P. Szaflarski,Hervé Besson, Wendyl D’Souza, Edward Faught,Pavel Klein,Markus Reuber,Felix Rosenow,Javier Salas-Puig, Victor Soto Insuga,Bernhard J. Steinhoff,Adam Strzelczyk, Dimitrios Bourikas,Tony Daniels, Florin Floricel, David Friesen,Cédric Laloyaux,Vicente Villanueva

Journal of Neurology（2024）

引用 0|浏览4

暂无评分

摘要

To assess the effectiveness and tolerability of brivaracetam (BRV) in adults with epilepsy by specific comorbidities and epilepsy etiologies. EXPERIENCE/EPD332 was a pooled analysis of individual patient records from several non-interventional studies of patients with epilepsy initiating BRV in clinical practice. Outcomes included ≥ 50

查看译文

关键词

Brivaracetam,Real world,Comorbidity,Etiology,Effectiveness,Tolerability

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要